{"TopicDetails": {"type": 0, "ccm2Id": 46932855, "cftId": 0, "identifier": "EU4H-2024-PJ-01-1", "title": "Call for proposals on the European Hub for vaccine development (HERA) - CP-g-24-10", "publicationDateLong": 1716422400000, "callIdentifier": "EU4H-2024-PJ-01", "callTitle": "HERA Action Grants -  first wave", "callccm2Id": 46932879, "allowPartnerSearch": true, "frameworkProgramme": {"id": 43332642, "abbreviation": "EU4H", "description": "EU4 Health Programme (EU4H)"}, "programmeDivision": [{"id": 44176618, "abbreviation": "Protecting", "description": "Protecting people in the Union from serious cross-border threats to health and strengthening the responsiveness of health systems and coordination among the Member States"}, {"id": 44176644, "abbreviation": "Supporting", "description": "Supporting integrated and coordinated work between Member States"}], "topicMGAs": [], "tags": ["STEP-Biotech"], "sme": false, "actions": [{"status": {"id": 31094502, "abbreviation": "Open", "description": "Open"}, "types": [{"typeOfAction": "EU4H-PJG EU4H Project Grants", "typeOfMGA": [{"id": 43326018, "abbreviation": "EU4H-AG", "description": "EU4H Action Grant Budget-Based"}]}], "plannedOpeningDate": "23 May 2024", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["05 September 2024"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3541705": [{"action": "EU4H-2024-PJ-01-3 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "23 May 2024", "deadlineModel": "single-stage", "deadlineDates": ["05 September 2024"], "budgetYearMap": {"2024": 17000000}, "budgetTopicActionMap": {}}], "3541707": [{"action": "EU4H-2024-PJ-01-1 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "23 May 2024", "deadlineModel": "single-stage", "deadlineDates": ["05 September 2024"], "budgetYearMap": {"2024": 102000000}, "budgetTopicActionMap": {}}], "3541709": [{"action": "EU4H-2024-PJ-01-2 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "23 May 2024", "deadlineModel": "single-stage", "deadlineDates": ["05 September 2024"], "budgetYearMap": {"2024": 20000000}, "budgetTopicActionMap": {}}], "3541711": [{"action": "EU4H-2024-PJ-01-4 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "23 May 2024", "deadlineModel": "single-stage", "deadlineDates": ["05 September 2024"], "budgetYearMap": {"2024": 10000000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2024"]}, "description": "<SPAN class=\"topicdescriptionkind\">Objective</SPAN>:<p>This action supports the policy priority to enhance crisis preparedness and response for future health emergencies in relation to medical countermeasures, with a focus on priority pathogens with pandemic potential. It implements the EU4Health Programme\u2019s general objective of improving the availability, accessibility and affordability of crisis-relevant products (Article 3, point (c)) through the specific objectives defined in Article 4, points (b) and (c), of Regulation (EU) 2021/522.</p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>This action aims to create a European Hub for public health-relevant vaccine development, combining excellence in vaccine development with clinical trials and activities for scaling manufacturing. This call targets consortia of developers of vaccines covering expertise in development including publicly funded and industrial organisations.</p><p>The Hub will develop a strategic vaccine plan for Europe, and subsequently deliver on creating vaccine prototypes in particular for priority pathogens with epidemic and pandemic potential, further developing of state-of-the-art technologies that can be rapidly adapted, preparing relevant master clinical trial protocols, combining its activities to reach out to clinical trial capacities/networks and at scale production initiatives at national and European levels. The Hub should establish connections with private manufacturers including through specific manufacturing agreements such as EUFAB or comparable national models.</p>\n<SPAN class=\"topicdescriptionkind\">Expected Impact</SPAN>:<p>This action is expected:</p><p>a) to contribute to better preparedness and early response to health emergencies;</p><p>b) to increase the availability and uptake of public health-relevant vaccines and antibodies;</p><p>c) to contribute to the availability of preventive measures to slow the spread of selected pathogens;</p><p>d) to reduce strategic dependencies, and expand Europe\u2019s competitiveness and strategic autonomy.</p>\n", "conditions": "<p><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\">Conditions<br />\r\n<br type=\"_moz\" />\r\n</span></b></p>\r\n<p><b><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:&#10;text1;mso-themetint:191;mso-ansi-language:EN-US\">1.&nbsp;</span></b><b><span lang=\"EN-US\">Admissibility conditions: </span></b><span lang=\"EN-US\">described in section 5 of the call document</span>&nbsp;</p>\n<p><b><span lang=\"EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\">&nbsp;described in Part B of the Application Form available in the Submission System</span></p>\n<p><b><span lang=\"EN-US\">2. Eligible countries:&nbsp;</span></b><span lang=\"EN-US\">described in section 6 of of the call document</span></p>\n<p><b><span lang=\"EN-US\">3. Other eligibility conditions:</span></b><span lang=\"EN-US\">&nbsp;described in section 6 of the call document</span></p>\n<p><b>4. Financial and operational capacity and exclusion:&nbsp;</b>described in&nbsp;<span lang=\"EN-US\">section 7 of the call document</span></p>\n<p><b><span lang=\"FR-BE\">5.&nbsp;Evaluation and award:</span></b></p>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Award criteria, scoring and thresholds:</span></b><span lang=\"EN-US\">&nbsp;described in section 9 of the call document</span></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">Submission and evaluation processes</span></b><b><span lang=\"EN-US\">:</span></b><span lang=\"EN-US\">&nbsp;described&nbsp;<span style=\"color: rgb(64, 64, 64);\">section 8 of the call document and the</span>&nbsp;</span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span lang=\"EN-US\">Online Manual</span></a></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Indicative timeline for evaluation and grant agreement:&nbsp;</span></b><span lang=\"EN-US\">described in section 4 of the call document</span></li>\r\n</ul>\n<p><b><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">6</span></b><b><span lang=\"EN-US\">. Legal and financial set-up of the grants:&nbsp;</span></b><span lang=\"EN-US\">described&nbsp;<span style=\"color: rgb(64, 64, 64);\">in section 10 of the call document</span></span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\">Documents<br />\r\n<br />\r\n<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\"><b><span lang=\"EN-US\">Call documents:</span></b></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2024/call-fiche_eu4h-2024-pj-01_en.pdf\" target=\"_blank\">Call document </a><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"box-sizing: inherit; font-size: 16px; line-height: 1.4; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/temp-form/af/af_eu4h_en.pdf\" target=\"_blank\" style=\"box-sizing: inherit; background-color: initial; touch-action: manipulation; text-decoration-line: none; position: relative; cursor: pointer !important;\">Standard application form ([ToA])</a>&nbsp;</span></p>\r\n<p class=\"MsoNormal\" style=\"box-sizing: inherit; font-size: 16px; line-height: 1.4; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/temp-form/af/detailed-budget-table_eu4h_en.xlsx\" target=\"_blank\" style=\"box-sizing: inherit; background-color: initial; touch-action: manipulation; text-decoration-line: none; position: relative; cursor: pointer !important;\">Detailed budget table ([ToA])</a></span></p>\r\n<p class=\"MsoNormal\" style=\"box-sizing: inherit; font-size: 16px; line-height: 1.4; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span style=\"box-sizing: inherit;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/agr-contr/mga_eu4h_en.pdf\" target=\"_blank\" style=\"box-sizing: inherit; background-color: initial; touch-action: manipulation; text-decoration-line: none; position: relative; cursor: pointer !important;\">EU4Health Programme General MGA v1.1</a></span></p>\r\n<p style=\"box-sizing: inherit; font-size: 16px; line-height: 1.4; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span class=\"MsoHyperlink\" style=\"box-sizing: inherit;\"><span style=\"box-sizing: inherit;\"><a href=\"https://health.ec.europa.eu/publications/2024-eu4health-work-programme_en\" target=\"_blank\" style=\"box-sizing: inherit; background-color: initial; touch-action: manipulation; text-decoration-line: none; position: relative; cursor: pointer !important;\">EU4Health Work Programme 2024</a></span></span></p>\r\n<p class=\"MsoNormal\" style=\"box-sizing: inherit; font-size: 16px; line-height: 1.4; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0522\" target=\"_blank\" style=\"box-sizing: inherit; background-color: initial; touch-action: manipulation; text-decoration-line: none; position: relative; cursor: pointer !important;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\">EU4Health&nbsp;</span></a><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0522\" target=\"_blank\" style=\"box-sizing: inherit; background-color: initial; touch-action: manipulation; text-decoration-line: none; position: relative; cursor: pointer !important;\">Regulation 2021/522</a></span></span></p>\r\n<p class=\"MsoNormal\" style=\"box-sizing: inherit; font-size: 16px; line-height: 1.4; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\"><br style=\"box-sizing: inherit;\" />\r\n</span><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\" style=\"box-sizing: inherit; background-color: initial; touch-action: manipulation; text-decoration-line: none; cursor: pointer !important;\"><span lang=\"EN-US\" style=\"box-sizing: inherit;\">EU Financial Regulation 2018/1046</span></a></p>\n", "supportInfo": "<p><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">For help related to this</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">&nbsp;</span><b style=\"font-family: Arial, sans-serif; font-size: 9pt;\">call</b><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">, please contact:</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">&nbsp;</span><font face=\"Arial, sans-serif\">HaDEA-HP-CALLS@ec.europa.eu</font></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;grantAndTendertype=1;categories=p_submission_eval;programme=null;actions=;keyword=;period=null\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Funding &amp; Tenders Portal FAQ</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Submission of proposals.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">IT Helpdesk</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Contact the IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Online+Manual\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Online Manual</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Step-by-step online guide through the Portal processes from proposal preparation and submission to reporting on your on-going project. Valid for all 2021-2027 programmes.</span></p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [{"callIdentifier": "EU4H-2024-PJ-01", "status": "Open", "criterionType": "SubFundingScheme", "criterionTypeDescription": "subfunding schemes", "criterionCode": "EU4H-PJG", "criterionDescription": "EU4H Project Grants", "url": "https://ec.europa.eu/research/participants/submission/manage/screen/submission/create-draft/36919?topic=EU4H-2024-PJ-01-1", "startDate": "May 23, 2024 12:00:00 AM", "endDate": "Sep 5, 2024 5:00:00 PM", "mgaDescription": "EU4H Action Grant Budget-Based", "mgaCode": "EU4H-AG"}], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"latestInfos": [{"approvalDate": "May 23, 2024 12:00:01 AM", "lastChangeDate": "May 23, 2024 12:00:01 AM", "content": "The submission session is now available for: EU4H-2024-PJ-01-1(EU4H-PJG), EU4H-2024-PJ-01-3(EU4H-PJG), EU4H-2024-PJ-01-4(EU4H-PJG), EU4H-2024-PJ-01-2(EU4H-PJG)"}], "hasForthcomingTopics": false, "hasOpenTopics": true, "allClosedTopics": false}}}